Halozyme Therapeutics posts strong Q1 2025 earnings with 35% revenue growth, robust pipeline, and rising royalties.

Diana Fishbein, Nova Institute for Health scholar, ASDN Coordinating Committee member, and University of North Carolina ...

ABC News' Dr. Tara Narula breaks down a new study suggesting that a common HIV medication may significantly reduce the risk ...

AARP also calls on Congress to protect and strengthen Medicare’s ability to negotiate lower drug prices for millions of older ...

Today, thanks to that sequence of contributions, the first HIV drug to offer long-lasting protection from infection - eliminating the need for people to take a daily pill - exists. For their role ...

President Donald Trump will announce a plan to lower U.S. prescription drug costs by tying the amount the government pays for some medications to prices paid abroad, according to an administration ...

Pharmaceuticals represent a critical component of modern healthcare, yet their costs remain a major source of concern for governments, private insurers, and especially consumers. In recent years ...

Lenacapavir, a first-in-class capsid inhibitor, is notable for its ability to inhibit HIV at multiple stages of its lifecycle. The drug has already been green-lit in multiple countries for the ...

Investing.com -- President Donald Trump is set to revive an initiative aimed at drastically reducing drug costs by linking the amount the government pays for certain medicines to lower prices in other ...

The pharmaceutical industry estimates President Donald Trump’s new drug pricing proposal could cost drug companies as much as $1 trillion over a decade, its largest trade group is telling ...

WASHINGTON (Reuters) -U.S. President Donald Trump is expected to sign an executive order as early as next week that would revive an effort to decrease drug costs by tying the amount the government ...